3-year real world outcomes with benralizumab for severe eosinophilic asthma

被引：0
|
作者：
Palmer, H. [1 ]
Whitehurst, C. [2 ]
Hince, K. [2 ]
Khurana, S. [2 ]
Tavernier, G. [1 ]
Elsey, L. [2 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.413
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
M24
引用
收藏
页码：A274 / A275
页数：2
相关论文
共 50 条
  • [31] Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years' Therapy
    Fyles, Fred
    Nuttall, Amy
    Joplin, Hannah
    Burhan, Hassan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09): : 2715 - 2723
  • [32] Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
    Gomez-Bastero Fernandez, Ana
    Medina Gallardo, Juan Francisco
    Delgado Romero, Julio
    Romero Falcon, Auxiliadora
    Benito Bernaldez, Cristina
    Gallego Borrego, Javier
    Javier Alvarez-Gutierrez, Francisco
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 727 - 735
  • [33] Predictor of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [34] Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Takanori Numata
    Hanae Miyagawa
    Saiko Nishioka
    Keitaro Okuda
    Hirofumi Utsumi
    Mitsuo Hashimoto
    Shunsuke Minagawa
    Takeo Ishikawa
    Hiromichi Hara
    Jun Araya
    Kazuyoshi Kuwano
    BMC Pulmonary Medicine, 20
  • [35] Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Nishioka, Saiko
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [36] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [37] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
    Gonzalez I, Davila
    Benitez F, Moreno
    Quirce, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
  • [38] The clinical profile of benralizumab in the management of severe eosinophilic asthma
    Menzella, Francesco
    Lusuardi, Mirco
    Galeone, Carla
    Facciolongo, Nicola
    Zucchi, Luigi
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (06) : 534 - 548
  • [39] Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma
    Sakai, Natsumi
    Koya, Toshiyuki
    Murai, Yui
    Tsubokawa, Fumito
    Tanaka, Kentaro
    Naramoto, Shun
    Aoki, Ami
    Shima, Kenjiro
    Kimura, Yosuke
    Watanabe, Satoshi
    Hasegawa, Takashi
    Kikuchi, Toshiaki
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, : 783 - 791
  • [40] Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
    Noorduyn, Stephen G.
    Johnston, Karissa
    Osenenko, Kathy
    Sriskandarajah, Niroshan
    Gendron, Alain
    Mbuagbaw, Lawrence
    ERJ OPEN RESEARCH, 2021, 7 (04)
12345